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DURING the past 16 months, horses have 
been immunized in our laboratories against 
the lymphoid tissue of both dogs and man. 
From the beginning, it was evident that the 
resultant equine antibodies had substantial 
lymphopenic and immunosuppressive quali- 
ties, as proved after administration of the 
horse serum or plasma to both dogs which 
had and those which had not received trans- 
plants. However, excessive toxicity pre- 
cluded the use of such biologic materials in 
human immunosuppressive regimens. Fur- 
thermore, the antibody titers in the early 
preparations were so low that large volunies 
were necessary for an effect, mak i~g  admin- 
istration impractical. 
Ultimately, means were found to raise 
very high titers of antibody against either 
human or dog lymphoid tissue. The active 
principle was found to be in the gamma G 
globulin and in other immunoglobulin frac- 
tions. A protein derivative which included 
these components was separated which was 
of such potency that it caused lymphopenia 
in both dogs and man when given subcu- 
taneously or intramuscularly in small vol- 
umes. This product has been used by us for 
immunosuppression of a number of patients 
after renal homotransplantation (26). How- 
ever, the present report is not concerned 
with the protection afforded by these prod- 
ucts to homografts but rather with obser- 
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METHODS 
Immunization. Ten horses which weighed 
400 to 500 kilograms were inoculated sub- 
cutaneously with canine lymphoid tissue. 
Spleen was the only source of antigen in 4 
animals, and the other 6 were injected with 
both lymph nodes and spleen. The number 
of sacrificed canine donors for the individual 
horses ranged from 10 to 30. 
Two other horses weighing 425 and 610 
kilograms were inoculated with human 
lymphoid tissue from 6 and 21 cadaveric 
donors respectively after a maximum post- 
mortem delay of 150 minutes. One of the 2 
animals received lymph nodes, thymus, and 
spleen, and the other received only spleen. 
Both the human and canine tissues were 
prepared in the same way. The lymph 
nodes and thymuses were washed in chilled 
normal saline immediately after extirpa- 
tion. The spleens were perfused through the 
splenic artery with 2 to 6 liters of chilled 
lactated Ringer's solution. The lymphoid 
tissue was then ground up and passed 
through progressively h e r  mesh stainless 
steel filters, the last denier being 40. The 
cells in the h a 1  suspension were counted, 
the type of cells was determined with differ- 
ential counts after Wright staining, and the 
incidence of cell viability estimated after 
staining with trypan blue. The cell popula- 
tion of the final saline suspension consisted 
of 85 to 99 per cent lymphocytes, 1 to 15 per 
cent granulocytes, and a few red cells. Al- 
most 100 per cent of the nucleated cells were 
viable. 
The immunization schedule was irregu- 
lar. In general, however, the first 4 to 6 
inoculations were at  weekly intervals, with 
subsequent booster doses as indicated on the 
basis of the horse leukoagglutinin titers. The 
cell doses ranged from 0.2 to 194 b:ll' ion. 
The dose-response relationship is discussed 
later. When the horses were bled, 5 to 10 
liters were removed. 
Equine immunologic response. Serial leuko- 
agglutinin titers against the white cells of 
dog or human buffy coat were measured in 
the immunized horse serum by a modifica- 
tion of the methods of Payne and Dausset. 
Serial twofold dilutions of test serum were 
made in buffered saline. The titer was ex- 
pressed as the reciprocal of this dilution. To 
each dilution, an equal volume, 0.1 milli- 
liter of leukocyte suspension was added and 
incubated a t  37 degrees C. for 1 hour. Spot 
checks of lymphocytoagglutinins in the same 
serums were made using dog and human 
thoracic duct lymphocytes for test cells. 
Hemagglutinins against dog and human red 
cells were also determined using a 1.5 per 
cent red cell suspension in saline added to 
an equal volume of serum. Readings were 
taken after incubation for 30 minutes at 37 
degrees C. 
Antilymphoid substances studied. Antidog- 
lymphoid plasma with titers of 1 : 16 to 1 :256 
was first used. The horses were bled into 
heparinized bottles. The plasma was sepa- 
rated by centrifugation, heated at 56 degrees 
C. for 30 minutes, passed through Seitz fil- 
ters, pooled with the plasma of several other 
horses, and given to dogs by intraperitoneal 
injection. 
Next, pooled antidog-lymphoid serum 
was prepared from the coagulated blood of 4 
of these same horses. This serum was heated 
as described and absorbed for 15 minutes at  
37 degrees C. against 10 per cent pooled dog 
red cell pack. It was then used for intraperi- 
toneal injections. The titer was 1 :32 to 1 : 128. 
When high titer antidog-lymphoid serum 
was eventually obtained, more extensive 
absorption procedures were tried, first by 
mixing 1 volume of pooled normal dog 
serum, which had been heated at 56 degrees 
C. for 30 minutes, to 10 parts of immune 
horse serum. The mixture was incubated 
for 12 hours a t  4 degrees C., centrifuged at 
6,000 revolutions per minute for 30 minutes 
and the sediment discarded. The residual 
serum was then absorbed 4 times with 30, 
30, 20, and 10 per cent washed dog red cell 
pack for 1 to 2 hours a t  4 degrees C. In addi- 
tion, some serums were absorbed against 10 
to 25 per cent dog kidney cell pack, and 
against 20 to 30 per cent liver cell pack. 
Details of preparation of cell pack from the 
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ABSORBED ANTISERUM 
Precipitation with (NH,),SO, 
I 
0.33, 0.35, 0.4, and 0.5 saturation 
I J. 
Centrifugation (discard supernatant) 
I J. 
Dialysis against H,O and saline 
Lyophilization 
I J. 
Reconstitute in H 2 0  
Leukoagglutinin andllymphoagglu- 
tinin titer 
Test 
Fractionation of precipitated 
protein with DEAE cellulose 
Leukoagglutinin and lympho- 
agglutinin titer of each fraction 
Immunoelectrophoresis J 
of active fractions + Lyophilization of active fractions I J. 
Reconstitution in H 2 0  
4 
Dialyzed against saline 
I J. 
Filtration 
Test 
FIG. 1. The methods used for preparation of crude horse globulin from absorbed serum and for 
determination of the antibody-containing portions of the globulin. 
solid organs is described elsewhere (1 1). The 
volume of supernatant after each absorption 
was approximately the same as the original 
serum volume. 
The antihuman-lymphoid serum was 
treated in the same way. Blood from 10 to 
20 human donors of all blood types was 
separated into red cells and serum. The 
serum was pooled as were the red cells after 
washing 3 times with saline. Details of ab- 
sorption were as described in the foregoing. 
When kidney and liver tissues were used for 
absorption, these were obtained from fresh 
cadavers and perfused free of blood with 
chilled lactated Ringer's solution before 
preparation of the parenchymal cell pack. 
For reasons discussed subsequently, most of 
the antihuman serum was absorbed only 
with red cells and serum. 
Several fractions were prepared from the 
absorbed antihuman and antidog-lymphoid 
serum (Fig. I), using standard biochemical 
methods. For each, the starting point was 
precipitation with ammonium sulfate at  0.33, 
0.35,0.4, or 0.5 saturation. In a few instances 
precipitation was performed at 0.35 satura- 
tion and a reharvest of the supernatant a t  
0.5 saturation was later obtained, but in most 
only a single precipitation was employed. 
Many of tlie protein precipitates obtained 
with ammonium sulfate were concentrated 
by lyophilization and stored. The precipitate 
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was dialyzed a t  room temperature against 
tap water for 24 hours and then at 4 degrees 
C. for 12 hours against saline. The crude 
globulin was then lyophilized, stored in vac- 
uum bottles, and placed in a desiccator. For 
use, the powder was reconstituted with 1 
volume of distilled water for every 4 volumes 
of the original horse serum. The sodium 
chloride content of the powder plus the dis- 
tilled water made up a h a 1  solution of ap- 
proximately physiologic saline. It  was steri- 
lized by passage through a Seitz filter and 
stored a t  -20 degrees C. The titer of the 
antidog globulin was 1 :512 to 1 :1024. The 
antihuman material had a titer of 1 :4096 to 
1 :16,384. 
Fractionation of both the raw serum and 
the ammonium sulfate precipitate was per- 
formed with diethylaminoethanol cellulose 
anion exchangers by the method of Sober 
and Peterson. Eluates from the diethylamino- 
ethanol cellulose columns were subjected to 
electrophoresis by the Beckman microzone 
electrophoresis system using phosphate buf- 
fer o f p ~  8.0,0.075 M. Immunoelectrophore- 
sis was by the method of Scheidegger. For 
the latter exaniinations a barbiturate buffer 
of 0.1 M and PH 8.6 was used. The current 
was 100 volts, 5 milliamperes, applied for 60 
minutes. 
Studies after administration. Mortality and 
the incidence of toxic reactions were deter- 
mined for each antilymphoid substance. The 
effects upon renal and hepatic function and 
upon formed blood elements were monitored 
in both the dogs and patients. 
Precipitin titers against normal horse 
serum were determined as a measure of the 
canine or human response to the immune 
horse globulin, employing a twofold dilution 
test which was read with the naked eye. Dog 
or human serum was added to an equal 
volume of normal horse serum, incubated 
for 30 minutes a t  37 degrees C. and 30 
minutes a t  room temperature. In addition, 
intradermal skin test reactions to 0.1 milli- 
liter of the protein product used clinically 
were measured before and a t  intervals after 
the institution of therapy. Readings were 
taken after 30 minutes and 24 hours. 
Finally, the patient serums were assayed for 
hemagglutinin titers against sheep red blood 
cells to determine if Forssman-like anti- 
bodies developed, using the double dilution 
method described earlier to study horse 
hemagglutinins. 
Pathologic studies. The dogs which had re- 
ceived antilvmphoid products were au- 
topsied and all the tissues studied by light 
microscopy. A number of animals had 
biopsies which permitted electronmicro- 
scopic analysis of the kidneys, lymph nodes, 
spleen, or liver, as well as examination of 
frozen tissues. 
The tissues were classified according to 
the type and route of therapy used: 
Six dogs without transplants which re- 
ceived 1 to 4 milliliters per kilogram per 
day unabsorbed immune plasma intraperi- 
toneally until their death after 8 to 13 days. 
Ten dogs without transplants which re- 
ceived 2 to 6 milliliters per kilogram per day 
partially absorbed immune serum intra- 
venously for 6 to 70 days. The 2 animals 
treated for 70 days had biopsies, followed by 
cessation of therapy for 15 days a t  which 
time they were rebiopsied and sacrificed. 
Two dogs without transplants which re- 
ceived 1 to 4 milliliters per kilogram per day 
of the same serum described in group 2 but 
by the intraperitoneal route. One was 
treated for 33 days and died. The other had 
45 days of injections. Therapy was then 
stopped for 28 days after which time biopsies 
were obtained. 
Two dogs whose kidneys, spleen, and 
lymph nodes were studied 74 and 76 days 
after orthotopic liver transplantation. These 
animals had received 51 and 30 days of in- 
traperitoneal treatment respectively with 
the same serum described in group 2. 
Therapy had been stopped for 51 and 75 
days before the biopsies. No other immuno- 
suppressive therapy was given. 
Two dogs without transplants which 
received 17 days of subcutaneous therapy 
with immune serum which had been ab- 
sorbed completely with red cells as well as 
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FIG. 2. Effect of immunizing dose upon the leukoagglutinin titer of a horse inoculated with cadav- 
eric human lymphoid tissue. Note that the rise in titer was very modest during the first 3 months, 
during which time small doses of cells were used. When the quantity of antigen was increased by 
the use of spleen cells, abrupt increases in titer were observed within a few days. 
with kidney and liver. They died of sub- 
cutaneous sepsis. 
Six dogs which received 0.3 to 0.4 milli- 
liter per kilogram per day immune globulin 
subcutaneously for 31 to 56 days. The in- 
jectate had a protein content of 8 grams per 
cent. 
Three dogs whose kidneys, spleen, and 
lymph nodes were studied after 60 days of 
therapy with 0.2 milliliter per kilogram per 
day of immune globulin which had been 
started on the day of orthotopic liver trans- 
plantation. The injectate had a protein 
content of 4.6 grams per cent. No other 
immunosuppression was used. 
Four control dogs given subcutaneous in- 
jections for 30 days with lyophilized globu- 
lin prepared from normal nonirnrnunized 
horses. They received 0.63 milliliter per 
kilogram per day of an injectate containing 
4.5 grams per cent protein. 
In addition, the spleens were examined 
from 7 uremic patients who had received 
antihuman-lymphoid globulin for 5 to 35 
days. The specimens were removed at the 
time of renal homotransplantation. Lymph 
nodes were available from 3 of these pa- 
tients. The reconstituted globulin which had 
a leukoagglutination titer of 1 :8192 to 
1:16,384 was given intramuscularly in a 
dose of 4 milliliters per kilogram per day. 
Protein content was 8.7 grams per cent. 
RESULTS 
Influence of immunization variables. Early in 
the study when lymph nodes were used as 
the antigen source, the total weekly cell 
dose from dog donors ranged from 0.5 to 19 
billion. The horse immunized with human 
lymph node or thymus cells had irregularly 
spaced individual doses of 0.18 to 1.4 billion. 
Within a few weeks, the aritidog and anti- 
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TABLE I.-EFFECT OF ABSORPTION PROCEDURES 
UPON ANTIBODY TITERS IN THE SERUM FROM A 
HORSE IMMUNIZED AGAINST HUMAN LYMPH 
NODE, THYMUS, AND SPLEEN CELLS 
Antihuman 
Volume, Lcukoagglu- Hcmagglu- protein 
ml. finin tinin prccipitins 
Original antilymph- 
oid serum.. . . . . . . 2250 1:4096 1:16,384 1:64 
After serum absorp- 
tion (1 X). . . . . . . . 2370 1:4096 1:16,384 0 
After red cell ab- 
sorption (4 X) . . . . 2300 1 :4096 1 :2 0 
After kidney (1 X) 
and liver (1 X) 
absorption. . . . . . . 2400 1:1024 1 :2 0 
human leukoagglutinin titers increased from 
control values of 0 to 1 :4 to as high as 1 :256 
and 1:32 respectively. These titers did not 
rise further despite similar repeated booster 
doses over periods of as long as 6 months. 
Later, the antigen dose was radically in- 
creased by employing 4.1 to 194 billion 
spleen cells. The titers responded within a 
few days or weeks to levels of as high as 
1 : 16,384. An example in a horse immunized 
against human cells is shown in Figure 2. 
Subsequently, 4 additional horses were 
immunized with only canine spleen in 
weekly doses of 52 to 214 billion cells from 
the start, and a fifth animal was prepared 
with doses of 5.1 to 32 billion human spleen 
cells (Fig. 3). All 5 horses responded with 
leukoagglutinin titers of 1 :2048 to 1 :16,384 
within 20 to 75 days. With sufficiently large 
numbers of cells, a horse can thus be effec- 
tively im~nunized relatively quickly. 
Features of the equine immunologic response. 
The leukoagglutinin titers of both the anti- 
dog and the antihuman-lymphoid serums 
were approximately the same as the lympho- 
agglutinin titers determined by testing 
against thoracic duct lymphocytes of the 
respective species. 
Some variability of the effect of the crude 
globulin was evident inasmuch as the white 
cells from different donors were not all 
agglutinated to the same dilution. Thus 1 
batch, which agglutinated at 1:4096 for 6 
of a panel of 10 donor white cells, had a titer 
of 1 :2048 to 1 :16,384 for the others. Further- 
more, interspecies reactions were also noted. 
Antidog-lymphoid globulin of high titer 
also weakly agglutinated human white cells. 
A similar interspecies reaction was found 
with antihuman-lymphoid globulin. These 
interesting observations have been reported 
in detail by Putnam and his associates. 
The most easily studied undesirable anti- 
bodies were the hemagglutinins. The natural 
heterohemagglutinin titer against either dog 
or human red cells was 1:2 to 1:8. After 
immunization, the hemagglutinin titer rose 
to as high as 1 :100,000. The hemagglutinin 
titer usually exceeded that of the leuko- 
agglutinins. 
Eject of absorption on antibody titers. Ab- 
sorption with red cell pack removed es- 
sentially all hemagglutinins without affect- 
ing the leukoagglutinin titers. Absorption 
with pooled dog or human serum to remove 
antibodies against serum protein also did 
not reduce the leukoagglutinin titers. How- 
ever, a single exposure to kidney and liver 
cells caused the loss of 75 per cent or more 
of the antiwhite cell titer in both the antidog 
and the antihuman horse serum (Table I). 
With longer absorption periods or greater 
concentrations of liver and kidney cell 
pack, the loss of leukoagglutinin titer was 
even greater. When absorption with 50 per 
cent volume of either kidney or liver was 
carried out 4 times, the titer loss was ap- 
proximately 90 per cent. 
Efect of ammonium sulfate precipitation and 
lyophili<ation upon leukoagglutinin titers. A 
pooled collection of antidog horse serum 
was divided into 3 aliquots of 60 milliliters 
and each precipitated 4 times a t  either 0.33, 
0.4, or 0.5 saturation ammonium sulfate. 
The precipitate was dialyzed, reconstituted 
with water to the original serum volume, 
and again tested. The original titer of the 
serum was 1 :2048 and contained total pro- 
tein of 7.8 grams per cent. With precipi- 
tation at 0.33 saturation only 0.G gram per 
cent protein was recovered, and the recon- 
stituted product had a titer of 1 :64; the titer 
loss was therefore 94 per cent. In contrast, 
2.9 and 3.5 grams per cent of protein were 
retrieved at 0.4 and 0.5 saturation re- 
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FIG. 3. The leukoagglutinin response in a horse immunized solely with human 
spleen cells. The individual cell doses were 5 to 30 billion. Note the progressive 
increase in titer to 1 :4,096 after 80 days. 
spectively. In both, the titer of the recon- 
stituted material was 1 : 1024. 
A similar harmful effect of precipitation 
at too low a concentration of ammonium 
sulfate was demonstrable when this proceqs 
was carried out only once rather than 4 
times. Under these circumstances the agglu- 
tinin loss was usually negligible with pre- 
cipitation at either 0.4 or 0.5 saturation, 
but with 0.35 saturated solution 50 per cent 
or more of the antibody was lost. The effect 
of lyophilization on the leukoagglutinin 
titers was variable, but in some instances 
was significant. The various protein precipi- 
tates were further characterized as described 
subsequently. 
The nature of the antilymphoid antibody. Two 
milliliters of antihuman-lymphoid serum 
were applied to a 10 gram diethylamino- 
ethanol cellulose column and fractionated 
into 190 tubes, each containing 10 milli- 
liters. Elution was with phosphate buffers 
of PH 8 and 0.01 M, PH 7 and 0.02 M, PH 6 
and 0.05 M, PH 5 and 0.1 M, and PH 4.6 and 
0.15 M. The material in each collecting 
tube was tested for its ability to agglutinate 
white cell pack or pure thoracic duct lym- 
phocytes. The results are shown in Figure 4. 
The leukoagglutinins were positive in the 
fractions eluted w i t h p ~  8.They were present 
in even higher titer in the elutions at  PH 
7 andpH 6. By calculation of the curve areas, 
the eluates at  PH 8, 7, and 6 contained ap- 
proximately 30, 35, and 35 per cent of the 
antibody respectively. 
The proteins in the individual tubes were 
concentrated to one-tenth the collected 
volume by dialysis against carbowax and 
then analyzed electrophoretically and im- 
munoelectrophoretically to characterize the 
active protein. These studies (Fig. 4) showed 
that the leukoagglutinating elutions from 
PH 8 and PH 7 were gamma globulin. Those 
tubes with agglutinating antibodies from the 
PH 6 eluate had an electrophoretic mobility 
characteristic of a mixture of beta globulins, 
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FIG. 4. Studies of the leukoagglutinin-containing frac- photometrically for protein content, expressed as optical 
tions in antihuman-lymphoid serum with the use of density, and the presence or absence of leukoagglutinins 
column chromatography, electrophoresis, and immuno- determined for each collection tube. The electrophoresis 
electrophoresis. The various eluates from the diethyl- and immunoelectrophoresis permitted relatively com- 
aminoethanol cellulose column were analyzed spectro- plete classification of the active immunoglobulins. 
T equine fraction, and gamma globulins, a Exactly the same procedures were carried 
conclusion supported by the results of im- out on antidog serum which had been ab- 
munoelectrophoresis. The inactive tubes in sorbed with dog red cells, serum, kidney, 
t h e p ~  5 and PH 4.6 elutions contained alpha and liver. The residual leukoagglutinating 
globulins and albumin. antibody appeared in the same 3 eluates. 
Iwasaki et al .:  HORSE ANTIDOG A N D  ANTIHUMAN ANTILYMPHOID PLASMA OR SERUM 9 
ELECTROPHORESIS IMMUNOELECTROPHORESIS 
0 . 3 3  SAT. 
0.40 SAT. 
Fro. 5. Electrophoresis and immunoelectrophoresis of the horse protein obtained 
by precipitating 4 times at different saturations of ammonium sulfate. Note the 
progressively heterogeneous nature of the precipitate with higher ammonium sulfate 
concentrations. The globulin obtained with 0.4 saturation was used clinically. 
Finally, the same analysis was applied to 
precipitates obtained from unabsorbed anti- 
dog serum with 0.33, 0.4, and 0.5 saturation 
ammonium sulfate. After precipitation 4 
times with 0.33 saturation, and diethylarni- 
noethanol cellulose chromatographic sepa- 
ration, the eluate at  PH 8 had a moderately 
reduced quantity of protein which was 
shown to be pure gamma G globulin by 
electrophoresis and immunoelectrophore- 
sis. The other eluates including those anti- 
body fractions a t  p~ 7 and PH 6 contained 
only a trace of protein. 
In contrast, the precipitates obtained with 
0.4 and 0.5 saturation ammonium sulfate 
had eluates at  PH 8, 7, and 6 which resem- 
bled those of raw serum and which also had 
electrophoretic and irnrnunoelectropho~tic 
properties of gamma and beta globulins and 
the equine T fraction. Only traces of addi- 
tional protein were found in the other elu- 
ates from the material precipitated at 0.4 
saturation. At 0.5 saturation, however, sig- 
nificant quantities of alphat macroglobulins 
and traces of albumin were contaminants. 
Selection of an antilymphoid product for clinical 
use. These results explain the critical effect 
of ammonium sulfate concentration upon 
the potency of the final product as de- 
scribed earlier. With too low a saturation, 
pure gamma G globulin (Fig. 5, top) is 
obtained but with a reduced quantity of the 
desired antibody. With too high a satura- 
tion, the penalty for retention of the anti- 
body is the necessity to accept contarnina- 
tion with extraneous horse protein (Fig. 5, 
bottom). Therefore, the technique finally 
adopted for clinical use was double precipi- 
tation with 0.4 saturation, a method which 
usually permits retention of approximately 
50 per cent of the leukoagglutinating anti- 
bodies with a minimum of unwanted 
components. 
The features of a batch of antihuman- 
lymphoid globulin prepared by this method 
are illustrated in Figure 6. The volume of 
serum processed was 2,400 milliliters. After 
absorption with red cell pack and serum, it 
had a titer of 1 :8,192. Following 2 precipita- 
tions with 0.4 saturation ammonium sulfate, 
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FIG. 6. Electrophoresis and immunoelectrophoresis of absorbed antihuman- 
lymphoid serum and the protein obtained from it by 2 precipitations with 0.4 
saturated ammonium sulfate, 2 dialyses, and lyophilization. The final product, 
which was used clinically, consists almost entirely of gamma G globulin. 
2 washings, and lyophilization, the final 
product, which was reconstituted to 810 
milliliters, had a titer of 1:8,192. Although 
the antibody loss during preparation was 
thus approximately 67 per cent, the final 
product was still sufficiently potent for use 
in small volumes. Of the 205 grams protein 
in the raw serum, 56.7 grams or 22 per cent 
had been retained. The refined material 
consisted almost entirely of gamma globulin 
with a trace of beta globulin. 
In our hands, the most practical means 
to date for globulin preparation has been 
with the ammonium sulfate method. How- 
ever, the results with column chromatogra- 
phy prompted efforts to separate therapeu- 
tic quantities of the leukoagglutinating anti- 
body with diethylaminoethanol cellulose 
columns. Raw serum or crude globulin 
obtained from a single precipitation with 
0.4 saturation ammonium sulfate was used 
for substrate. In all our early efforts using 
various PH and phosphate buffer strengths, 
the loss of leukoagglutinin titer in the re- 
sultant purified protein was 90 per cent or 
more. More recently, using a single column 
separation atpH 6 and a phosphate buffer of 
0.05 My 60 per cent of the antibody was re- 
tained. The facility with which this method 
can be applied commercially may make it 
the preferred technique for production in 
the future. 
Mortality from serum. Thirty-six dogs with- 
out transplants were given 1 to 4 milliliters 
per kilogram per day unabsorbed anti- 
lymphoid plasma which had a leukoagglu- 
tinin titer of l : l 6  to 1:256. Eleven of the 
animals died within 15 days. The greatest 
risk was with the first few injections. Often, 
generalized convulsionsdeveloped. In others, 
acute anemia contributed to the morbidity. 
The antilymphoid serum which had been 
partially absorbed with dog red cells was 
also given intraperitoneally in the same dose 
to 19 dogs for 16 to 22 days. There were no 
deaths during this period. This serum given 
intravenously in doses of 2 to 6 milliliters per 
kilogram per day to 10 other dogs caused 
the death of 4 animals. Four others received 
renal or hepatic homotransplantation after 
10, 11, 21, and 23 days; these animals, 
which were ill, all died promptly. The other 
2 dogs continued to receive serum intra- 
venously for 70 days. 
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FIG. 7. The effect of horse plasma or serum and crude horse globulin upon the hematocrit, lympho- 
cyte count, total white count, and white count differential during 15  days of daily administration. 
In all but the control experiments on the right, the agents were prepared from horses immunized 
against dog lymphoid tissue. Note that acute anemia was largely prevented only when complete 
absorption had been carried out with canine red cell pack. 
Crude globulin prepared from the serum 
of immunized horses was given subcutane- 
ously to 29 dogs without transplants for 8 to 
60 days in doses of 0.2 to 0.5 milliliter per 
kilogram per day. Leukoagglutinin titers 
were 1 : 5 12 to 1 : 1,024. Two animals died of 
subcutaneous coliform infection. There was 
no other mortality. Although the crude 
globulin used was variable, having been 
precipitated with 0.35, 0.4, or 0.5 satura- 
tion ammonium sulfate, no difference in 
toxicity of the different products was evi- 
dent. Furthermore, there was no apparent 
difference in safety if absorption of the 
original serum had been accomplished with 
canine red cells, serum, kidney, and liver as 
compared to that if absorption had been 
only with red cells and serum. 
There was no mortality from globulin 
used clinically on patients. 
The injuence of antilymphoid products upon the 
peripheral blood. The canine response to anti- 
lymphoid plasma or serum and various 
globulin derivatives is summarized in Figure 
7, along with results obtained from 4 control 
animals which received globulin prepared 
from the serum of a nonimmunized horse. 
Lymphopenia was produced with each of 
the antilymphoid preparations but not with 
the nonspecific horse serum. The most easily 
demonstrable effect was upon the lympho- 
cyte differential count. The diminution in 
the absolute lymphocyte counts was less 
striking because of the increase in the total 
white cell count which almost invariably oc- 
curred. There was very often an increase in 
immature granulocyte forms. All of these 
changes tended to occur quickly. After an 
injection, the reduction in lymphocytes was 
first detectable within 2 to 6 hours (Fig. 8), 
with a maximum effect in 8 to 24 hours. 
With the discontinuance of therapy (Fig. 
9), the return of peripheral lymphocytes 
was usually complete within 5 to 10 days. 
Although the lymphopenic effect was thus 
comparable with both the unpurified and 
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Fm. 8. The acute response in dogs of the lymphocyte differenti& Absolute 
lymphocyte count, and total white count to subcutaneous crude horse globulin 
prepared from the serum of immunized horses. The dose of globulin was 0.2 to 0.4 
milliliter per kilogram per day with a leukoagglutinin titer of 1:512 to 1:1,024. 
Note that the lymphopenic effect is clearly demonstrable in 4 to 6 hours and that it 
lasts for at least 1 day. 
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FIG. 9. The effect in dogs of 2 separate courses of globulin prepared from the serum of immunized 
horses. Note the rapid recovery from the lymphopenia when the drug was discontinued after 15 
days of therapy, and the recurrent lymphopenic response to a second course of injections started 16 
days later. "Stabs" refer to nonsegrnented neutrophiles. 
purified antilymphoid substances, there was unabsorbed antilymphoid plasma or anti- 
an important difference in the effect upon lymphoid serum which had been subjected 
the hematocrit. In the animals which re- to partial red cell absorption, acute anemia 
ceived intraperitoneal injections of either developed. This undesirable effect was even 
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FIG. 10. The effect of antihuman-lymphoid globulin in 6 patients treated daily 
for 5 days before renal homotransplantation. "Stabs" refer to nonsegmented neu- 
trophiles. 
more pronounced when antilymphoid serum 
was given intravenously (Fig. 7). This com- 
plication was not present in most of the 
globulin products derived from horse serum 
which had been completely absorbed with 
dog red cells. However, isolated batches of 
the latter material also caused anemia de- 
spite the proved absence of hemagglu- 
tinins. 
Six patients had similar studies during 
the daily intramuscular administration of 
immune horse globulin for 5 days prior to 
renal homotransplantation. The material 
which had a leukoagglutinin titer of 1 33,192 
to 1 : 16,384 was given in 4 milliliter doses. 
The results were similar to those in dogs in 
that the lymphocyte differential count was 
immediately decreased in all (Fig. 10). 
However, total increases in white count also 
invariably occurred with the result that the 
absolute fall in lymphocyte count was not 
statistically significant. The course of a 
seventh patient who was awaiting a cadaveric 
kidney is shown during a 35 day period 
(Fig. 11). In the last patient, the initial re- 
duction in the lymphocyte differential was 
not well sustained after 2 weeks. The anemia 
which was present in these uremic patients 
prior to therapy did not seem to be made 
worse. 
Evidence of toxicity in patients. An annoying 
side effect of the antilymphoid globulin in 
the patients was intense pain a t  the site of 
the intramuscular injection, particularly for 
the first few days. The patients usually did 
not complain a t  the time of injection but 
from 2 to 4 hours later a sensation of a 
muscle cramp was described. Several found 
that the symptoms could be alleviated by 
exercise, and in all the pain diminished with 
subsequent injections. In 1 patient narcotics 
were initially necessary. By the following 
morning the patients were usually symptom- 
free. These cyclic events were accompanied 
by variable degrees of swelling and edema 
around the injection sites. In  all of the pa- 
tients fever developed, as shown in one 
patient in Figure 11. 
Immunologic measurements in the host. In 4 
dogs which were given crude globulin ob- 
tained from the serum of normal horses high 
precipitin titers developed against normal 
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horse serum within 11 days (Fig. 12). In 
contrast, dogs receiving globulin derived 
from the serum of horses immunized with 
dog lymphoid tissue had precipitin titer 
rises no greater than 1 : 16 during the first 
30 days (Fig. 12). Four other dogs had 
similar treatment with immune globulin for 
15 to 17 days. With discontinuance of in- 
jections for 17 days, the precipitin titers, 
which had increased to a maximum of 1 :8, 
returned to 0 or 1:2. After resumption of 
therapy, the precipitin titers rose again but 
did not exceed 1:8 during the next 25 
days of continuous injections. Spot checks 
in 4 other dogs which had received immune 
horse globulin therapy from 20 to 100 days 
previously all had antihorse-protein pre- 
cipitin titers of less than 1:4. These data 
suggest that the risk of delayed serum sick- 
ness after cessation of therapy is not exces- 
sive, and that a prior course does not neces- 
sarily preclude later repeat treatment. 
Antihorse precipitin titers were also 
determined during 2 to 3 months of serum 
therapy for 7 patients who had received 
transplants. Before operation these patients 
received only antilymphoid globulin, but 
afterward they also were treated with 
azathioprine, and in some instances pred- 
nisone. The precipitin titers increased from 
control values in 6 instances to 1 :4 or 1 :8 
and in the other to 1 :32 (Fig. 11). 
The hemagglutinin titers against sheep 
red cells were studied in the 7 patients dur- 
ing the same intervals. In 2 patients these 
rose from 1:2 to 1:256 or 1:512. In 2 others, 
the titer rose to 1:32, and in the other 3 
there was no increase. The patients were 
also studied with serial skin tests (Fig. 11). 
The skin reaction after 2 to 3 months 
showed no change in 1, a slight increase in 
4, a moderate increase in 1, and a decrease 
in the other. 
Eject  on renal and hepatic function. Bio- 
chemical evidence of injury to either the 
kidney or liver was detectable only when 
the partly absorbed antilymphoid serum 
was given intravenously in doses of 4 to 6 
milliliters per kilogram per day. Two of 
these dogs became uremic. Four of the 
animals had rises in serum glutamic ox- 
alacetic transaminase or serum glutamic 
pyruvic transaminase, and 2 of the 4 became 
clinically jaundiced. There was no evidence 
of renal or hepatic injury with the same 
doses of this material given intraperitoneally 
for a t  least 15 days. 
The same studies were also determined in 
29 dogs which were subcutaneously ad- 
ministered the globulin derivatives prepared 
from immune horse serum. Abnormalities 
did not develop in a single one of these dogs 
during the period of study. 
The 7 patients who received immune 
horse globulin had end-stage renal disease. 
A complete battery of liver chemistry tests 
repeated serially after the beginning of 
treatment was unchanged in each instance. 
Canine pathologic studies. Lymphoid hyper- 
plasia was present in many of the dogs 
treated with immune plasma, serum, or 
globulin, particularly in animals treated 
for 2 months or longer. In the spleens, the 
follicles were bigger and more numerous 
than in untreated dogs (Fig. 13). The follic- 
ular centers were crowded with large and 
medium-sized cells with lightly pyronino- 
philic cytoplasm and large, pale nuclei with 
prominent nucleoli. Many of these cells were 
in mitosis (Fig. 14). Ultrastructurally these 
pyroninophilic blast cells were characterized 
by the very numerous free ribosomes that 
filled their cytoplasm. The cells had only a 
very few flattened cisternal profiles of rough 
endoplasmic reticulum and moderate num- 
bers of mitochondria. The Golgi apparatus 
was usually well developed (Fig. 15). 
Reticular cells and macrophages were pres- 
ent and some contained ingested nuclear 
debris. The mantle and marginal layers of 
the follicles were greatly reduced in thick- 
ness and contained very few small lympho- 
cytes. In the periarteriolar sheaths of the 
red pulp there were many aggregates of 
lymphoid cells which were smaller and 
possessed more deeply pyroninophilic cyto- 
plasm than the cells in the follicles; there 
were also some plasma cells.. 
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In the majority of these treated animals 
the lymph nodes throughout the body were 
either normal in size or enlarged. The cortex 
contained numerous germinal centers com- 
posed of proliferating, large pyroninophilic 
cells similar in gross and h e  structure to 
those encountered in the splenic follicles 
(Fig. 16). The number of small lymphocytes 
surrounding these centers was greatly re- 
duced. The medulla contained varying 
numbers of smaller, deeply pyroninophilic 
cells and some plasma cells. 
The thymuses were normal for the age of 
the animals. There were no germinal centers. 
The kidneys were examined from 21 
dogs treated with immune plasma, serum, 
or globulin and compared with the kidneys 
from 4 control dogs similarly treated with 
subcutaneously injected globulin obtained 
from nonimrnunized horses. Two of the 4 
control animals had many dense deposits on 
the epithelial side of the glomerular capil- 
lary basement membranes. In some glom- 
eruli there were also deposits in the lam- 
ina densa, on the subendothelial aspect 
of the capillary basement membrane and in 
the mesangial matrix. These changes were 
associated with focal fusion of the epithelial 
foot processes and a variable amount of 
endothelial cell hyperplasia. The fluorescent 
antibody technique revealed horse gamma 
globulin, dog immunoglobulin G, and 
betalc complement as small beads in the 
glomerular capillary loops of the 2 dogs 
with ultrastructural deposits. By ordinary 
light microscopy, however, peiiodic acid- 
Schiff positive thickening of the glomerular 
capillary basement membranes could only 
be detected in 1 of the dogs. 
Ten of the 31 dogs treated with anti- 
lymphoid agents had periodic acid-Schiff 
positive thickening of the glomerular capil- 
lary basement membrane, evident with light 
microscopy (Fig. 17). Another 3 showed 
glomerular deposits only with the electron 
microscope. In the animals treated for the 
longest periods, these changes were oc- 
casionally accompanied by hypercellularity 
of the tufts and adhesions between tufts and 
capsules. Ultrastructurally, the same dense 
deposits were present on the subepithelial 
aspects of the glomerular capillary base- 
ment membranes and in the mesangium of 
these animals as were seen in the control 
group treated by normal horse globulin 
(Figs. 18 and 19). The altered basement 
membranes stained positively for horse 
gamma globulin, dog immunoglobulin G, 
and betalc complement when treated with 
the appropriate immunohistochemical re- 
agents. Length of treatment was the im- 
portant factor determining whether renal 
lesions were present or not: the 13 dogs 
affected were all among the 21 animals who 
were treated for 17 days or longer. The 
route of administration was also important. 
The highest incidence of lesions was in the 
group given immune serum intravenously 
in which in all 6 of the animals treated for 
more than 17 days glomerular deposits 
developed. But even in the 11 animals 
treated subcutaneously for a comparable 
period, 6 showed glomerular deposits. 
The effectiveness of absorbing immune 
serum against kidney and liver tissue in re- 
ducing the frequency of renal lesions cannot 
be assessed from these experiments because 
the route of administration was not constant. 
Lesion developed in 8 of the 12 animals 
treated with antilymphoid products ab- 
sorbed only against red cells as compared 
with 4 of the 9 animals given completely 
absorbed materials. 
Two of the dogs in which large glomeru- 
lar deposits developed following 70 days of 
intravenous antilymphoid serum therapy 
were re-biopsied after treatment had been 
discontinued for 15 days. There was no evi- 
dence of reversal of the glomerular damage. 
A third animal which had not been biopsied 
previously showed small deposits 28 days 
after cessation of a 45 day course of intra- 
peritoneal antilymphoid serum. 
Consistent injury to other organs was not 
present. A few treated animals had focal 
myocardial and hepatic necroses, but these 
were related to terminal infection, nvt to a 
direct toxic effect of antilymphoid agents. 
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FIG. 12. The response of canine precipitin titers to horse protein during daily injection of globulin 
prepared from the serum of nonimmunized and immunized horses. Note the striking difference in 
the 2 groups of dogs. 
Pathologic studies in humans. The amount of 
lymphoid tissue appeared to be within the 
range of normal in the 7 spleens and 3 lymph 
nodes examined. Germinal centers com- 
posed of large, pale pyroninophilic cells 
were present in 6 of the 7 spleens and in all 
of the lymph nodes. The number of small 
lymphocytes surrounding these centers did 
not seem to be reduced. 
DISCUSSION 
Interest in the use of antilymphoid serum 
for the mitigation of homograft rejection 
dates from the relatively recent reports of 
Woodruff (28-30), Waksman, Jeejeebhoy, 
Gray (7) and Monaco (17) and their as- 
sociates. However, the first experiments 
with this type of agent were performed by 
Metchnikoff, who clearly appreciated the 
potential therapeutic value of such serum 
products. In 1899, he wrote somewhat 
philosophically of the struggle between the 
various cells of an organism and added, 
"The time is not remote when medical art 
will actively intervene to maintain the in- 
tegrity of the whole organism, the harmony 
of which is broken by the preponderance of 
certain cells, mononuclear cells in the atro- 
phies, several other elements in the malig- 
nant diseases. Therefore I undertook the 
study of the effect produced by the resorp- 
tion of macrophages. To attain this end I 
initially injected guinea pigs subcutaneously 
with an emulsion of rat spleen or lymph 
nodes ground up in saline solution. Forty- 
seven days after this injection, guinea pig 
serum agglutinated and dissolved rat leuko- 
cytes. Mononuclear cells were the most 
sensitive and were converted into trans- 
parent vesicles. Later the granulocytes 
underwent the same changes and finally the 
mast cells.'' Metchnikoff pointed out that 
nonimmunized serum did not have these 
properties. In addition, he observed that 
guinea pig serum immunized against rats 
did not agglutinate lymphocytes from other 
species. 
The material used by Metchnikoff was 
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FIG. 13. Two large follicles in the spleen of a dog which 
had been treated for 56 days with absorbed immune 
globulin given subcutaneously. The follicular centers 
(fc) appear dark gray because thcy are occupied by cells 
which have only a little pyronin-positive cytoplasm. In  
the red pulp groups of cells, which appear black because 
they have a greater amount of deep red cytoplasm, are 
clustered along the arterioles and small arteries (arrows). 
Methyl green pyronin, X20. 
unaltered guinea pig antiserum. Subse- 
quently, Pappenheimer showed that absorp- 
tion by red cells of the lymphoid donor species 
did not reduce the antileukocyte activity, a 
finding confirmed by Cruickshank, Sacks, 
Levey (14) and Gray (8) and their associ- 
ates. Pappenheimer's studies indicated as 
well that inactivation of complement by 
heating at 56 degrees C. for 30 minutes 
diminished the cytotoxic but not the leuko- 
agglutinating activity. The latter observa- 
tion was extended by Gray, Monaco, Wood 
and Russell, who were able to restore full 
cytotoxicity by the addition of complement. 
The latter investigators also showed that 
absorption of the antiserum by serum of 
the lymphoid donor species did not affect 
FIG. 14. Higher magnification of one of the follicular 
centers shown in Figure 13. I t  is composed of large and 
mcdium-sized cells each with a thin rim of red cytoplasm 
which appears black in this photograph. The nuclei are 
large. The unstained areas are the cytoplasm of macro- 
phages. Two cells are in mitosis (arrows). Methyl green 
pyronin, X250. 
the leukoagglutinin titer. These important 
details, originally described in various ro- 
dent species, appear from the results in the 
present study to apply largely to horse serum 
immunized against dog and human lym- 
phoid tissue. In our preparations, the ab- 
sorption with red cells seemed to be of the 
utmost importance, since the high titers of 
hemagglutinins probably contributed to the 
anemia otherwise invariably seen in the 
recipients of the immune serum. In anti- 
serums such as some of those described by 
Monaco, LiVood, Gray and Russell (16) and 
Levey and Medawar (13) in which hemag- 
glutinin titer rises in the serum donor were 
not excessive, this step was apparently 
unnecessary. 
In contrast, agreement concerning the 
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FIG. 15. Dividing large blast cell from splenic white 
pulp shown in Figures 13 and 14. The cytoplasm is filled 
with ribosomes grouped in clusters. There are a few 
solitary profiles of endoplasmic reticulum. Lead hy- 
droxide, X5,064. 
effect of absorption of the antiserum by 
nucleated cells of the donor species is less 
complete. All workers from Pappenheimer 
to the present time who have performed the 
necessary experiments agree that the anti- 
serum is largely inactivated if it is exposed 
to lymphoid tissue of the original donor 
species, a finding confirmed in the present 
study. However, experiments involving ab- 
sorption with tissues such as kidney, liver, 
lung, and skeletal muscle have yielded 
divergent results. Sacks, Fillipone, and 
Hume demonstrated antibody fixation of 
their serums to liver, kidney, and muscle, 
but the consequent effect upon antiserum 
titer was not specified. Levey and Medawar 
(13) initially noted little loss of potency 
when antiguinea pig lymphocyte serum was 
exposed to guinea pig liver, kidney, and 
lung, but in subsequent studies the same 
investigators noted a very definite reduction 
in potency after exposure to scrupulously 
washed kidney and lung brei. Such infor- 
mation was specifically sought by Gray, 
Monaco, Wood, and Russell, who, despite 
the demonstration of antibody binding to 
liver, kidney, and skeletal muscle by gel 
FIG. 16. Many large germinal centers (gc) in  a lymph 
node from a dog which had been treated intravenously 
with antilymphoid serum for 70 days. Hematoxylin and 
eosin, X20. 
diffusion studies, could not document a 
consequent fall in either leukoagglutinating 
or cytotoxic antibody titers. The latter 
studies supported the hope that a highly 
specific antilymphoid preparation was easily 
attainable, which would have an action 
directed solely against lymphocytes. 
The findings in the present study are at 
variance with those of Gray, Monaco, Wood 
and Russell. Instead, they support the con- 
clusions of Sacks, Fillipone and Hume, and 
Levey and Medawar (14) that there is con- 
siderable cross reactivity between all cells 
of the species being treated and that if anti- 
gens are uniquely represented in the lym- 
phocytes, they are relatively few in number. 
Levey and Medawar (14) have strengthened 
this conclusion in a crucial experiment in 
which serums were raised in rabbits by 
immunization with mouse epidermal cells 
or L-cells from tissue culture. Mice treated 
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FIG. 17. Microscopic section from the kidney of a dog 
which had been treated intravenously with partially ab- 
sorbed antilymphoid serum for 70 days. The glomerular 
capillary basement membranes and the mesangium are 
thickened. Periodic acid-Schiff, X250. 
with the resulting antiserums had definite 
prolongation of skin homograft survival. 
In the present study, the ease with which 
cross reactivity could be demonstrated be- 
tween various nucleated cells of the same 
species may have been a t  least partially due 
to the very high leukoagglutinating titers of 
the materials being studied. These ranged 
from 1 : 1,024 to 1 : 16,384, whereas the titers 
when stated in earlier investigations never 
exceeded 1 :64. The same difference in ex- 
perimental design may explain the lack of 
complete species specificity documented for 
the first time in the present report. The lat- 
ter finding suggests the presence of at  least 
a few cross reacting antigens in the dog and 
human white cells. 
The lack of strict immunologic specificity 
of the antiserums is not necessarily a fatal 
flaw. Our data suggest that a small residual 
fraction of antileukocyte activity is retained 
after repeated absorption by kidney and 
liver cells, so that, if necessary, attempts 
could be made toward purification of this 
antibody. Alternatively, there is reason to 
believe that the lymphoid system is a highly 
vulnerable target, against which antibody 
action will be more effective than against 
liver, kidney, and other organs despite the 
fact that the nonlyrnphoid tissues possess 
potential binding sites. Using unabsorbed 
serums, Levey and Medawar (13) were able 
to show that florescein-tagged antibody 
was heavily concentrated in the lymphoid 
elements. 
Although the proper choice of absorption 
techniques is an important first step, the 
necessity of obtaining purified products 
from the resulting antiserums is evident. 
The first steps in this direction were taken 
by Waksman and his associates, who re- 
ported that crude globulin obtained by 
ammonium sulfate precipitation was nearly 
as potent as the original antiserum. These 
findings have been confirmed by Gray, 
Monaco, Wood, and Russell and Monaco, 
Wood, Gray and Russell and in the present 
report. The development of more effective 
techniques to obtain high titer raw serum 
has made it possible further to refine the 
globulin fraction into a clinically usable 
form. The exact technique by which this is 
done is of the utmost importance in our 
experience, inasmuch as it appears likely 
that the desired antibody is located not only 
in the gamma G globulin but also in the 
beta globulin fraction. With improper selec- 
tion of ammonium sulfate concentration, 
much or even most of the antibody is not 
recovered in the precipitate. Separation of 
globulin by column chromatography is an 
even more critical procedure. Nevertheless, 
the studies herein reported suggest that with 
properly controlled variables, column sepa- 
ration may ultimately prove to be the best 
method for bulk production. 
The response of dogs and man to anti- 
lymphoid serum or its derivatives is not 
dissimilar to that reported in rodents by 
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FIG. 18. Fine structure of glomerulus from kidney 
shown in  Figure 17. Sharply outlined dense deposits 
(arrows) protrude from the capillary basement mem- 
branes toward the urinary space (err). Similar deposits are 
present in the mesangium (m). Over the deposits some of 
the epithelial foot processes are fused. An endothelial cell 
(end) is enlarged. cap, Capillary lumen; ep, epithelial cell. 
Phosphotungstic acid, X4,000. 
Chew and Lawrence and many subsequent 
investigators, except that the resulting lym- 
phopenia is not so profound. The fact that 
ammonium sulfate-precipitated globulin can 
be administered with little grossly observ- 
able acute toxicity has raised the impor- 
tant possibility of adding this agent to 
human immunosuppressive regimens. Nev- 
ertheless, there are several important ques- 
tions of long term morbidity which can be 
fully answered only by further experience. 
Many of the earlier workers alluded to the 
fact that their antiserum was well tolerated, 
but the periods of administration were lim- 
ited to a few days or weeks. More recently, 
Monaco, Wood, Gray, and Russell have 
described a wasting disease in mice heavily 
treated with rabbit antiserum which killed 
FIG. 19. Fine structure of glomerulus from dog treated 
with immune globulin subcutaneously 57 days. The 
original antiserum had been absorbed against dog kidney, 
liver, and red cclls. Subepithelial dense deposits (arrows), 
less severe than those in Figure 18, are on the capillary 
basement membranes. cap,  Capillary lumen; end, endo- 
thelial cell; rbc, red cell; ep, epithelial cell; w, urinary 
space. Phosphotungstic acid, X4,000. 
all their animals within 42 to 56 days. At 
autopsy there was virtually complete lym- 
phoid depletion, a finding contrary to the 
histologic observations of lymphoid hypcr- 
plasia made by Chew and Lawrence, Cruick- 
shank, and Levey and Medawar (14) but in 
accord with those of VVaksman. In our an- 
imals the striking feature was not atrophy 
but loss of small lymphocytes and their re- 
placement by large numbers of actively di- 
viding large and medium-sized pyronino- 
philic blast cells similar to those described 
by Movat and Harris and their associates 
during antibody formation, by &\vans and 
McGregor during graft-versus-host reac- 
tions, and by Inman and Cooper after 
stimulation by phytohemagglutinin. These 
findings are compatible with Levey and 
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Medawar's hypothesis (14) that the im- 
munosuppressive effect of antilymphoid sub- 
stances is not dependent upon a lymphocidal 
action but may be by stimulating transfor- 
mation of lymphocytes in a manner akin to 
that of phytohemagglutinin. 
The variant results cited may be due to 
differences in the vigor of therapy in the 
different experiments. The question of 
proper dose control is important in another 
context. One of the potential limiting factors 
in the use of heterologous antiserum has 
been the fear that the foreign protein would 
cause serum sickness. Gray, Monaco, Wood, 
and Russell and Levey and Medawar (13) 
carried out elegant studies to determine if 
mice were capable of developing antibodies 
against the rabbit protein of their anti- 
lymphoid serums. Both groups found that 
immunosuppression was complete enough so 
that the appearance of antirabbit-protein 
antibodies was prevented or greatly re- 
duced. These studies validated a hypoth- 
esis first suggested by Sacks, Fillipone, and 
Hume that the heterologous antiserum 
would exert a self-antidotal role in prevent- 
ing serum sickness. 
This concept is further strengthened by 
the data in the present study. The develop- 
ment in dogs of precipitin antibodies against 
normal horse serum was very rapid when 
nonimmune serum was employed. In con- 
trast, the response was both delayed and 
attenuated with the use of globulin products 
prepared from immunized horses, and 
sinilar observations were made in the pa- 
tients. However, these studies and those of 
the previous workers were for relatively 
short periods and do not preclude this 
complication with chronic therapy. The 
possible clinical dilemma in terms of long 
term prolongation of organ homografts is 
evident. To avoid the threat of serum 
sickness, very complete immunosuppression 
is required. If such total or near total im- 
munosuppression is achieved, it may be that 
morbidity similar to that in Monaco's mice 
will be encountered in man. 
In addition, the question of renal injury 
by chronic injection of foreign protein ap- 
pears to be equally important. Although 
previous studies with administration of anti- 
lymphoid serum have not documented this 
complication, it is well known that similar 
experimental techniques may produce glom- 
erular injury. Dixon, Feldman and Vaz- 
quez showed that the critical factor for 
production of lesions was that the animal 
should produce barely sufficient antibody 
to neutralize the injected antigen. The minor 
rises in antibody titer observed after admin- 
istration of antilymphoid agents to our dogs 
were clearly sufficient in many instances to 
produce renal damage following the forma- 
tion of circulating antigen-antibody com- 
plexes. The kidney is merely a receptacle for 
these complexes and is not a specific im- 
munologic target. Conceivably, the most 
useful role of the antilymphoid substances in 
clinical immunosuppressive regimens will 
only be for a short term course of therapy 
during the first critical weeks or months 
after operation. This is a particularly impor- 
tant possibility since Feldman has shown in 
the rabbit that the glomerular damage, once 
established, persists for more than a year 
after termination of antigen administration. 
Finally, additional information is badly 
needed concerning the most effective meth- 
ods of raising antiserum. In our experiments, 
heavy reliance was placed upon the spleen 
as an antigen source for reasons of con- 
venience. However, Nagaya and Sieker 
have claimed that rabbit antiserums were 
twice as effective in preventing skin homo- 
graft rejection in mice when immunization 
was with mouse thymocytes as opposed to 
lymph node lymphocytes. The question 
they have raised of the superiority of 
different lymphoid tissues as antigen will 
require careful study, as will the possibility 
that safer and more potent serums can be 
raised in animals other than the horse. 
SUMMARY 
Horses were immunized against dog or 
human lymphoid tissue with multiple sub- 
cutaneous injections of fresh lymph nodes, 
I~vasaki et ad.: HORSE ANTIDOG AND A 
thymus, and spleen. The equine antibody 
response, as gauged hy the titer of leuko- 
agglutinating antibodies, was small when 
the immunizing dose of donor cells ranged 
from 0.5 to 19 billion. When this dose was 
increased to as much as 200 billion spleen 
cells, the titers rose rapidly to as high as 
1 : 16,384. With in vitro testing, the antibody 
tended to agglutinate equally the white 
cells present in white cell pack and pure 
lymphocyte suspensions obtained from the 
thoracic duct. A weak cross species aggluti- 
nation was observed, indicating a lack of 
absolute species specificity. Furthermore, 
the ability to agglutinate white cells of 
different members of the lymphoid donor 
species was variable, suggesting a degree of 
individual specificity. An undesired col- 
lateral response was a rise in the horse 
hemagglutinin titer. 
Absorption of the immune horse serum 
with the red cells or serum from the species 
that had donated the lymphoid tissue for 
immunization did not alter the antiwhite 
cell titer. In contrast, repeated absorption 
with either kidney or liver resulted in a titer 
loss of approximately 90 per cent. This find- 
ing indicates that most of the antigens in the 
lymphocyte are represented in other tissues, 
and that the antiserums are capable of re- 
acting with other than lymphoid tissues. 
Fractionation of the antilymphoid anti- 
body was carried out with ammonium 
sulfate precipitation. The most effective 
concentration was at 0.4 saturation, which 
when done twice allowed recovery of ap- 
proximately half of the antibody with a 
minimum of contamination with extraneous 
horse protein. Further studies with column 
chromatography, electrophoresis, and im- 
munoelectrophoresis demonstrated the pres- 
ence of agglutinating antibodies in the 
gamma G, T equine, and beta globulin 
fractions. 
Various antilymphoid products were test- 
ed in vivo. In dogs, unabsorbed antitjmph- 
oid plasma, antilymphoid serum which was 
partially absorbed with red cells, anti- 
lymphoid serum which was completely 
absorbed with red cells, serum, liver, or 
kidney, and the raw globulin precipitated 
from absorbed antiserum all had a lympho- 
penic effect. With the progressive stages of 
refinement, the morbidity from therapy 
was reduced. Inasmuch as immune horse 
globulin was well tolerated in dogs, a com- 
parable product was developed and used 
for 7 patients who were prospective recipi- 
ents of renal homografts. In both dogs and 
man, a low titer response of precipitin 
antibodies to normal horse serum was 
documented. 
In the lymphoid tissues of the treated 
animals small lymphocytes were replaced 
by large and medium-sized proliferating 
cells with pyroninophilic cytoplasm, and 
gernlinal center formation was common. 
These findings are compatible with Levey 
and Medawar's hypothesis that at least one 
action of antilymphoid agents is to stimulate 
transformation of lymphocytes and that its 
immunosuppressive effect is not dependent 
upon lymphocyte killing. 
Although changes in blood urea nitrogen 
could be produced only by giving antilym- 
phoid serum intravenously, there was a high 
incidence of histologic renal damage with 
various antilymphoid agents after all routes 
of administration. The renal injury consisted 
of dense accumulations of horse and dog 
gamma globulin, together with comple- 
ment, along the subepithelial aspects of the 
renal glomerular capillary basement mem- 
branes. Once developed, these deposits 
persisted for at  least 28 days after injections 
were stopped. The incidence of these lesions 
was highest when the antilymphoid serum 
was given intravenously. Prior absorption 
of the serum with dog kidney and liver did 
not prevent the renal deposits from occur- 
ring. 
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